Opus Capital Group’s GSK GSK Stock Holding History

Opus Capital Group’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-6,936	Closed	-$362K	–	182
2019 Q1	$362K	Hold	6,936	–	–	0.1%	160
2018 Q4	$331K	Hold	6,936	–	–	0.07%	171
2018 Q3	$348K	Sell	6,936 -928	-12%	-$47.1K	0.08%	183
2018 Q2	$396K	Hold	7,864	–	–	0.1%	151
2018 Q1	$384K	Buy	+7,864	New	+$366K	0.1%	157
2017 Q4	–	Sell	-7,856	Closed	-$399K	–	247
2017 Q3	$399K	Buy	7,856 +1,144	+17%	+$58K	0.09%	157
2017 Q2	$362K	Hold	6,712	–	–	0.07%	145
2017 Q1	$354K	Hold	6,712	–	–	0.05%	182
2016 Q4	$323K	Hold	6,712	–	–	0.05%	184
2016 Q3	$362K	Sell	6,712 -78	-1%	-$4.28K	0.07%	145
2016 Q2	$368K	Hold	6,790	–	–	0.08%	144
2016 Q1	$344K	Buy	6,790 +78	+1%	+$3.88K	0.08%	153
2015 Q4	$339K	Hold	6,712	–	–	0.06%	204
2015 Q3	$323K	Hold	6,712	–	–	0.05%	201
2015 Q2	$349K	Buy	6,712 +736	+12%	+$41.4K	0.05%	189
2015 Q1	$345K	Hold	5,976	–	–	0.05%	192
2014 Q4	$319K	Hold	5,976	–	–	0.05%	198
2014 Q3	$343K	Sell	5,976 -9,188	-61%	-$563K	0.05%	200
2014 Q2	$1.01M	Buy	15,164 +1,640	+12%	+$111K	0.07%	118
2014 Q1	$903K	Hold	13,524	–	–	0.06%	113
2013 Q4	$903K	Buy	+13,524	New	+$877K	0.05%	114
2013 Q3	–	Sell	-7,548	Closed	-$471K	–	138
2013 Q2	$471K	Buy	+7,548	New	+$479K	0.03%	108

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Opus Capital Group's GSK Position: Q2 2019 in Review

Opus Capital Group sold out of GSK (GSK) in Q2 2019, closing a stake of 6,936 shares — an estimated $362K sold.

Opus Capital Group first reported a position in GSK in Q2 2013 and held it in 22 quarters. The position peaked at $1.01M in Q2 2014. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

Opus Capital Group reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
Opus Capital Group sold 6,936 GSK shares in Q2 2019, an estimated $362K.
Opus Capital Group first reported a position in GSK in Q2 2013 and held it in 22 quarters.
Opus Capital Group's GSK position peaked at $1.01M in Q2 2014.
804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Opus Capital Group's 13F filing for Q2 2019, filed 8 Aug 2019.